Year |
Citation |
Score |
2010 |
Gekas C, Rhodes KE, Van Handel B, Chhabra A, Ueno M, Mikkola HK. Hematopoietic stem cell development in the placenta. The International Journal of Developmental Biology. 54: 1089-98. PMID 20711986 DOI: 10.1387/ijdb.103070cg |
0.639 |
|
2010 |
Rhodes KE, Mikkola HKA. Hematopoietic Stem Cell Development in the Placenta Perinatal Stem Cells. 189-201. DOI: 10.1002/9780470480151.ch12 |
0.723 |
|
2009 |
Gekas C, Rhodes KE, Gereige LM, Helgadottir H, Ferrari R, Kurdistani SK, Montecino-Rodriguez E, Bassel-Duby R, Olson E, Krivtsov AV, Armstrong S, Orkin SH, Pellegrini M, Mikkola HK. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis. Blood. 113: 3461-71. PMID 19211936 DOI: 10.1182/Blood-2008-07-167577 |
0.65 |
|
2009 |
Rhodes KE, Van Handel B, Wang M, Wang Y, Chhabra A, Mikkola H. Blood Flow Is Required for the Release of Hematopoietic Stem- and Progenitor Cells From Hemogenic Endothelium in the Placenta. Blood. 114: 698-698. DOI: 10.1182/Blood.V114.22.698.698 |
0.703 |
|
2008 |
Gekas C, Rhodes KE, Mikkola HK. Isolation and visualization of mouse placental hematopoietic stem cells. Current Protocols in Stem Cell Biology. Unit 2A.8.1-2A.8.14. PMID 18729047 DOI: 10.1002/9780470151808.Sc02A08S6 |
0.685 |
|
2008 |
Schenke-Layland K, Rhodes KE, Angelis E, Butylkova Y, Heydarkhan-Hagvall S, Gekas C, Zhang R, Goldhaber JI, Mikkola HK, Plath K, MacLellan WR. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells (Dayton, Ohio). 26: 1537-46. PMID 18450826 DOI: 10.1634/Stemcells.2008-0033 |
0.724 |
|
2008 |
Rhodes KE, Gekas C, Wang Y, Lux CT, Francis CS, Chan DN, Conway S, Orkin SH, Yoder MC, Mikkola HK. The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell. 2: 252-63. PMID 18371450 DOI: 10.1016/J.Stem.2008.01.001 |
0.733 |
|
2007 |
Schenke-Layland K, Angelis E, Rhodes KE, Heydarkhan-Hagvall S, Mikkola HK, Maclellan WR. Collagen IV induces trophoectoderm differentiation of mouse embryonic stem cells. Stem Cells (Dayton, Ohio). 25: 1529-38. PMID 17363553 DOI: 10.1634/Stemcells.2006-0729 |
0.735 |
|
2007 |
Shankar DB, Li J, Tapang P, Owen McCall J, Pease LJ, Dai Y, Wei RQ, Albert DH, Bouska JJ, Osterling DJ, Guo J, Marcotte PA, Johnson EF, Soni N, Hartandi K, ... ... Rhodes K, et al. ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia. Blood. 109: 3400-8. PMID 17209055 DOI: 10.1182/Blood-2006-06-029579 |
0.31 |
|
2007 |
Rhodes KE, Gekas C, Wang Y, Lux CT, Francis CS, Conway S, Orkin SH, Yoder MC, Mikkola HK. Hematopoietic Stem Cells Emerge in the Placental Vasculature in the Absence of Circulation. Blood. 110: 1258-1258. DOI: 10.1182/Blood.V110.11.1258.1258 |
0.635 |
|
2006 |
Rhodes KE, Raivich G, Fawcett JW. The injury response of oligodendrocyte precursor cells is induced by platelets, macrophages and inflammation-associated cytokines. Neuroscience. 140: 87-100. PMID 16631314 DOI: 10.1016/J.Neuroscience.2006.01.055 |
0.335 |
|
Low-probability matches (unlikely to be authored by this person) |
2004 |
Hampton DW, Rhodes KE, Zhao C, Franklin RJM, Fawcett JW. The responses of oligodendrocyte precursor cells, astrocytes and microglia to a cortical stab injury, in the brain Neuroscience. 127: 813-820. PMID 15312894 DOI: 10.1016/J.Neuroscience.2004.05.028 |
0.259 |
|
2007 |
Carulli D, Rhodes KE, Fawcett JW. Upregulation of aggrecan, link protein 1, and hyaluronan synthases during formation of perineuronal nets in the rat cerebellum. The Journal of Comparative Neurology. 501: 83-94. PMID 17206619 DOI: 10.1002/Cne.21231 |
0.143 |
|
2003 |
Rhodes KE, Moon LD, Fawcett JW. Inhibiting cell proliferation during formation of the glial scar: effects on axon regeneration in the CNS. Neuroscience. 120: 41-56. PMID 12849739 DOI: 10.1016/S0306-4522(03)00285-9 |
0.137 |
|
2006 |
Carulli D, Rhodes KE, Brown DJ, Bonnert TP, Pollack SJ, Oliver K, Strata P, Fawcett JW. Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. The Journal of Comparative Neurology. 494: 559-77. PMID 16374793 DOI: 10.1002/Cne.20822 |
0.135 |
|
2005 |
Vallböhmer D, Zhang W, Gordon M, Yang DY, Yun J, Press OA, Rhodes KE, Sherrod AE, Iqbal S, Danenberg KD, Groshen S, Lenz HJ. Molecular determinants of cetuximab efficacy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3536-44. PMID 15908664 DOI: 10.1200/Jco.2005.09.100 |
0.122 |
|
2003 |
Dobbertin A, Rhodes KE, Garwood J, Properzi F, Heck N, Rogers JH, Fawcett JW, Faissner A. Regulation of RPTPβ/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia Molecular and Cellular Neuroscience. 24: 951-971. PMID 14697661 DOI: 10.1016/S1044-7431(03)00257-4 |
0.122 |
|
2008 |
Galtrey CM, Kwok JC, Carulli D, Rhodes KE, Fawcett JW. Distribution and synthesis of extracellular matrix proteoglycans, hyaluronan, link proteins and tenascin-R in the rat spinal cord. The European Journal of Neuroscience. 27: 1373-90. PMID 18364019 DOI: 10.1111/J.1460-9568.2008.06108.X |
0.115 |
|
2005 |
Rhodes KE, Vallböhmer D, Zhang W, Yang DY, Yun J, Press O, Gordon M, Iqbal S, Lenz HJ. Molecular predictor of irinotecan (CPT-11) efficacy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3560. PMID 27944442 DOI: 10.1200/jco.2005.23.16_suppl.3560 |
0.091 |
|
2002 |
Moon LD, Asher RA, Rhodes KE, Fawcett JW. Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat. Neuroscience. 109: 101-17. PMID 11784703 DOI: 10.1016/S0306-4522(01)00457-2 |
0.091 |
|
2007 |
Crespo D, Asher RA, Lin R, Rhodes KE, Fawcett JW. How does chondroitinase promote functional recovery in the damaged CNS? Experimental Neurology. 206: 159-71. PMID 17572406 DOI: 10.1016/J.Expneurol.2007.05.001 |
0.087 |
|
2006 |
Majed HH, Chandran S, Niclou SP, Nicholas RS, Wilkins A, Wing MG, Rhodes KE, Spillantini MG, Compston A. A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 1730-8. PMID 16467521 DOI: 10.1523/Jneurosci.0702-05.2006 |
0.082 |
|
2005 |
Gordon MA, Zhang W, Karaman M, Yun J, Press O, Rhodes K, Vallböhmer D, Iqbal S, Hacia J, Lenz HJ. Gene expression profiling associated with risk of recurrence in patients with colorectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3602. PMID 27945020 DOI: 10.1200/jco.2005.23.16_suppl.3602 |
0.078 |
|
2006 |
Zhang W, Gordon M, Press OA, Rhodes K, Vallböhmer D, Yang DY, Park D, Fazzone W, Schultheis A, Sherrod AE, Iqbal S, Groshen S, Lenz HJ. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab. Pharmacogenetics and Genomics. 16: 475-83. PMID 16788380 DOI: 10.1097/01.Fpc.0000220562.67595.A5 |
0.076 |
|
2006 |
Gordon MA, Gil J, Lu B, Zhang W, Yang D, Yun J, Schneider S, Groshen S, Iqbal S, Press OA, Rhodes K, Lenz HJ. Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation. Pharmacogenomics. 7: 67-88. PMID 16354126 DOI: 10.2217/14622416.7.1.67 |
0.071 |
|
2005 |
Zhang W, Park DJ, Lu B, Yang DY, Gordon M, Groshen S, Yun J, Press OA, Vallböhmer D, Rhodes K, Lenz HJ. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 600-5. PMID 15701846 |
0.07 |
|
2004 |
Rhodes KE, Fawcett JW. Chondroitin sulphate proteoglycans: Preventing plasticity or protecting the CNS? Journal of Anatomy. 204: 33-48. PMID 14690476 DOI: 10.1111/J.1469-7580.2004.00261.X |
0.07 |
|
2006 |
Zhang W, Stoehlmacher J, Park DJ, Yang D, Borchard E, Gil J, Tsao-Wei DD, Yun J, Gordon M, Press OA, Rhodes K, Groshen S, Lenz HJ. Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer. Clinical Colorectal Cancer. 5: 124-31. PMID 16098254 DOI: 10.3816/Ccc.2005.N.025 |
0.066 |
|
2006 |
Vallböhmer D, Iqbal S, Yang DY, Rhodes KE, Zhang W, Gordon M, Fazzone W, Schultheis AM, Sherrod AE, Danenberg KD, Lenz HJ. Molecular determinants of irinotecan efficacy. International Journal of Cancer. 119: 2435-42. PMID 16894565 DOI: 10.1002/ijc.22129 |
0.059 |
|
2005 |
Press OA, Zhang W, Yang DY, Yun J, Gordon M, Vallböhmer D, Rhodes KE, Iqbal S, Lenz HJ. Gender related survival differences associated with polymorphic variants of estrogen receptor beta (ERβ) and epidermal growth fact receptor (EGFR) in patients with metastatic colon cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3590. PMID 27944282 DOI: 10.1200/jco.2005.23.16_suppl.3590 |
0.055 |
|
2005 |
Yang DY, Vallböhmer D, Rhodes KE, Zhang W, Yun J, Press OA, Gordon M, Iqbal S, Danenberg KD, Lenz HJ. Molecular prognostic factors of irinotecan efficacy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3621. PMID 27944843 DOI: 10.1200/jco.2005.23.16_suppl.3621 |
0.054 |
|
2006 |
Rhodes KE, Zhang W, Yang DY, Gordon MA, Schultheis AM, Nagashima F, Iqbal S, Lenz H. Abcb1, ugt1a1 and oatp-c polymorphisms predict Irinotecan (CPT-11) toxicity Journal of Clinical Oncology. 24: 3074-3074. DOI: 10.1200/jco.2006.24.18_suppl.3074 |
0.051 |
|
2005 |
Zhang W, Vallböhmer D, Yang D, Yun J, Press OA, Gordon M, Rhodes K, Sherrod A, Iqbal S, Lenz HJ. Genomic profile associated with clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with epidermal growth factor receptor (EGFR) inhibitor cetuximab. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3557. PMID 27944429 DOI: 10.1200/jco.2005.23.16_suppl.3557 |
0.051 |
|
1972 |
Ehrenberg JR, Green CH, House LD, Rhodes KE, Winter RE. INCREMENTAL FEED MECHANISM Ibm Tech Disclosure Bull. 15: 2275-2276. |
0.046 |
|
2001 |
Moon LD, Asher RA, Rhodes KE, Fawcett JW. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nature Neuroscience. 4: 465-6. PMID 11319553 DOI: 10.1038/87415 |
0.041 |
|
2005 |
Zhang W, Gordon M, Yang D, Yun J, Press O, Rhodes K, Groshen S, Lenz H. Genomic Polymorphisms of Angiogenesis Pathway Predict Radiosensitivity in Rectal Cancer International Journal of Radiation Oncology*Biology*Physics. 63: S284. DOI: 10.1016/J.Ijrobp.2005.07.485 |
0.036 |
|
2008 |
Schultheis AM, Lurje G, Rhodes KE, Zhang W, Yang D, Garcia AA, Morgan R, Gandara D, Scudder S, Oza A, Hirte H, Fleming G, Roman L, Lenz HJ. Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7554-63. PMID 19010874 DOI: 10.1158/1078-0432.CCR-08-0351 |
0.034 |
|
2007 |
Rhodes KE, Zhang W, Yang D, Press OA, Gordon M, Vallböhmer D, Schultheis AM, Lurje G, Ladner RD, Fazzone W, Iqbal S, Lenz HJ. ABCB1, SLCO1B1 and UGT1A1 gene polymorphisms are associated with toxicity in metastatic colorectal cancer patients treated with first-line irinotecan. Drug Metabolism Letters. 1: 23-30. PMID 19356014 DOI: 10.2174/187231207779814328 |
0.024 |
|
1992 |
Rhodes KE. Prescription of diuretic drugs and monitoring of long-term use in one general practice British Journal of General Practice. 42: 68-70. PMID 1493009 |
0.024 |
|
2010 |
Rhodes KE, Simons JW, Soule HR. The Prostate Cancer Foundation 16th Annual Scientific Retreat: meeting report. The Prostate. 70: 916-20. PMID 20166134 DOI: 10.1002/pros.21127 |
0.01 |
|
1974 |
Andrews LP, Rhodes KE, Szczerbak RP, Winter RE. LOW-COST THERMAL PRINTER INCLUDING A SEMICONDUCTOR PRINT HEAD Ibm Tech Disclosure Bull. 16: 3634-3637. |
0.01 |
|
Hide low-probability matches. |